Mangoceuticals, inc. retains shareintel - shareholder intelligence services

Strengthens measures to protect shareholder interests through shareintel's dril-downtm process. dallas, tx / accesswire / march 30, 2023 / mangoceuticals, inc. ("mangorx" or the "company"), a company focused on developing, marketing and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ed) drug branded "mango," today announced that it has retained shareholder intelligence services, llc ("shareintel") for a 12-month, full-service agreement to review the trading of the company's common stock to track, identify and monitor for potential illegal short selling activities and deploy solutions to help combat any such activities.
MGRX Ratings Summary
MGRX Quant Ranking